Bioactive composites for bone regeneration. Review.

Bone regeneration therapies often rely on autologous or allogeneic bone grafts. These materials are used to fill bone defects and support new bone formation. However, their availability is limited, and they may carry risks of infection or immune rejection. Researchers have explored synthetic and natural alternatives to overcome these limitations. Ceramics like hydroxyapatite and tricalcium phosphate are commonly used for their osteoconductive properties. Polymers and co-polymers of alpha-hydroxy acids have also been investigated for their structural and biocompatible features. Despite their widespread use, these materials rarely exhibit osteoinductive properties on their own. This gap motivated the development of bioactive composites that combine osteoconductive scaffolds with osteogenic cells. The goal is to enhance the regenerative potential of these materials while minimizing the need for donor tissue.

The purpose of this review is to evaluate the potential of bioactive composites in bone regeneration. These composites integrate osteoconductive scaffolds with osteogenic cells to improve regenerative outcomes. The study aims to assess how these materials perform in both in vitro and in vivo settings. It seeks to clarify the mechanisms by which these composites support osteogenic differentiation. The review also explores the role of bone marrow-derived cells in enhancing the osteogenic potential of scaffolds. By analyzing the current literature, the study provides a synthesis of the evidence supporting the use of bioactive composites. It highlights the conditions under which these materials demonstrate osteoinductive properties. The findings may inform future strategies for developing more effective bone regeneration therapies.

This review synthesizes findings from multiple studies on bioactive composites for bone regeneration. The authors evaluated the osteoconductive and osteoinductive properties of various materials. They focused on ceramics such as hydroxyapatite and tricalcium phosphate. Polymers and co-polymers of alpha-hydroxy acids were also included in the analysis. The review examined how these materials interact with osteogenic cells, particularly those derived from bone marrow stroma. In vitro experiments were assessed for markers of osteogenic differentiation. In vivo studies were analyzed for evidence of bone histogenesis and marrow formation. The authors compared the performance of pure materials versus composites with cell integration.

Bioactive composites demonstrated enhanced osteogenic potential compared to pure materials. In vitro studies showed increased expression of alkaline phosphatase and collagen type I. Osteocalcin expression and mineralization were also observed in these composites. In vivo, the composites supported the formation of bone and later bone marrow. The integration of osteogenic cells on the scaffold surface was critical for these outcomes. Bone marrow-derived stromal cells were most frequently used in these experiments. The composites maintained osteogenic differentiation over time in both environments. These findings suggest that cell-scaffold integration improves regenerative outcomes.

The authors propose that bioactive composites offer a promising approach to bone regeneration. These composites combine osteoconductive scaffolds with osteogenic cells to enhance regenerative potential. The integration of bone marrow-derived cells appears to be a key factor in this process. In vitro and in vivo studies support the osteogenic differentiation of these composites. The findings suggest that these materials can support the histogenesis of bone and marrow. The authors highlight the importance of scaffold-cell interactions in achieving these outcomes. They suggest that further research is needed to optimize the composition and application of these composites. The review concludes that bioactive composites may provide a viable alternative to traditional bone grafts.